New World Evidence Data Market

Global New World Evidence Data Market, By Component (Dataset (Claims, Clinical, Pharmacy, and Patient) and Services), By Therapeutic Area (Oncology, Cardiovascular, and Immunology), By End-User (Pharmaceuticals, Medical Devices, Payers, and Providers), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029

PMI255719 | Healthcare IT

Oct 2019 | 178 | PDF

The New World Evidence Data Market is expected to reach $2.87 Billion by 2029, registering a CAGR of 14.4% from 2018 to 2029.Pharma and biopharma companies now recognize the need to get a better understanding and stronger evidence of product performance, clinical value and cost effectiveness outside the controlled environment and homogeneous setting of a clinical trial i.e. Randomized Clinical Trials (RCT) to inform decision making processes. With the growing need to achieve better value for healthcare, the importance of real-world evidence (RWE) as a decision-making tool and an important part of drug development and commercialization has also increased.

Drivers and Restraints:

Increasing geriatric population base and rise in the prevalence of chronic diseases is the major propelling factor for growth of the target market. For instance, in 2016, according to Health IT Buzz, in United States nearly 96% of hospitals and 78% of doctors use certified electronic health record systems. Additionally, shift from volume- to value-based care is another boosting factor for the growth of the global market. Moreover, the subsequent increase in development costs is also expected to propel growth of the target market over the forecast period. However, reluctance to rely on real-world studies may hamper growth of the global market in the coming years. In addition, lack of data processing infrastructure also hampers the growth of global new world evidences data market. Nevertheless, rise in focus on end- to- end RWE services creates a lucrative opportunity for the growth of the target market.

Simley face

Segmentation:

The global new world evidence data market is segmented based on component, therapeutic area, end- user, and region.

On the basis of component, the global new world evidence data market is segmented into dataset (claims, clinical, pharmacy, and patient) and services. On the basis of therapeutic area, the target market is segmented into oncology, cardiovascular, and immunology. Based on end- user, the global market is classified into pharmaceuticals, medical devices, payers, and providers.

Based on region the global new world evidence data market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America region is dominating the global new world evidence data market and is expected to maintain its dominace during the forecast paeriod. This is mainly attributed due to increasing geriatric population base in the North America region.

Key Players:

The key players operating the global new world evidence data market involves Oracle Corporation, IQVIA Holdings, Inc., International Business Machines Corporation, Syneos Health, Inc., ICON Public Limited Company, Pharmaceutical Product Development LLC, Optum, Inc., Cognizant Technology Solutions Corp., SAS Institute, Inc., and Flatiron Health, Inc. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market.

Detailed Segmentation:

Global New World Evidence Data Market, By Component:

  • Dataset
  • Claims
  • Clinical
  • Pharmacy
  • Patient
  • Services

 Global New World Evidence Data Market, By Therapeutic Area:

  • Oncology
  • Cardiovascular
  • Immunology

 Global New World Evidence Data Market, By End- User:

  • Pharmaceuticals
  • Medical Devices
  • Payers
  • Providers

 Global New World Evidence Data Market, By Region:

      • North America
        • North America New World Evidence Data Market, By Component
        • North America New World Evidence Data Market, By Therapeutic Area
        • North America New World Evidence Data Market, By End- User
        • North America New World Evidence Data Market, By Country
          • U.S.
          • Canada
      • Europe
        • Europe New World Evidence Data Market, By Component
        • Europe New World Evidence Data Market, By Therapeutic Area
        • Europe New World Evidence Data Market, By End- User
        • Europe New World Evidence Data Market, By Country
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
        • Asia Pacific New World Evidence Data Market, By Component
        • Asia Pacific New World Evidence Data Market, By Therapeutic Area
        • Asia Pacific New World Evidence Data Market, By End- User
        • Asia Pacific New World Evidence Data Market, By Country
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific                                                                                                                                  
      • Latin America
        • Latin America New World Evidence Data Market, By Component
        • Latin America New World Evidence Data Market, By Therapeutic Area
        • Latin America New World Evidence Data Market, By End- User
        • Latin America New World Evidence Data Market, By Country
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
        • Middle East & Africa New World Evidence Data Market, By Component
        • Middle East & Africa New World Evidence Data Market, By Therapeutic Area
        • Middle East & Africa New World Evidence Data Market, By End- User
        • Middle East & Africa New World Evidence Data Market, By Country
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Company Profile:

      • Oracle Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
  • IQVIA Holdings, Inc.
  • International Business Machines Corporation
  • Syneos Health, Inc.
  • ICON Public Limited Company
  • Pharmaceutical Product Development LLC
  • Optum, Inc.
  • Cognizant Technology Solutions Corp.
  • SAS Institute, Inc.
  • Flatiron Health, Inc.

 “*” marked represents similar segmentation in other categories in the respective section

Key Issues Addressed

  • What is the total revenue potential of the global new world evidence data market? How that market is expected to grow during the study period?
  • What are some of the major growth opportunities in the new world evidence data market?
  • Which companies are the major players in the new world evidence data market?

No data available what are you looking for? Kindly fill below form for your specific research requirement

 Can't read the image? click here to refresh.

Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Component
      • Market Snippet, By Therapeutic Area
      • Market Snippet, By End- User
      • Market Snippet, By Region
    • Opportunity Map Analysis
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  4. Global New World Evidence Data Market, By Component, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Database
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
        • Claims
        • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
        • Clinical
        • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
        • Pharmacy
        • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
        • Patient
        • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Services
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  1. Global New World Evidence Data Market, By Therapeutic Area, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Oncology
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Cardiovascular
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Immunology
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  2. Global New World Evidence Data Market, By End- User, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Pharmaceuticals
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Medical Devices
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Payers
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Providers
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  3. Global New World Evidence Data Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Component, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Therapeutic Area, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End- User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Component, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Therapeutic Area, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Component, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Therapeutic Area, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End- User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Component, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Therapeutic Area, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End- User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Component, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Therapeutic Area, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  4. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  5. Company Profiles
      • Oracle Corp.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • IQVIA Holdings, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • International Business Machines Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • ICON Public Limited Company
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Pharmaceutical Product Development LLC
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Optum, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Cognizant Technology Solutions Corp.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • SAS Institute, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Flatiron Health, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
  6. Section
    • Research Methodology
    • About Us
    • Contact

 

  • We at Prophecy Market Insights performs in-depth primary and secondary market research to identify market growth and restraining factors, opportunities, and trends, and to determine the key players in the target market, market size of the target market, leading products, leading applications in the target market, suppliers and distributors in the target market etc.
  • Primary Research – Prophecy Market Insights formulates a detailed discussion guide to perform primary research. In primary research collection of data is performed through telephonic interview, E-mail questionnaire’s, and in-depth discussion with industry experts, manufacturers, suppliers, distributors, and end-users. The primary research participant includes but not limited to CEO’s, Managers, Directors, VP’s, Suppliers, and CSO’s.
  • Secondary Research – Our research analyst performs in-depth secondary research and extensive data mining to collect market related information through various authentic data sources such as Government Portals, Annual Reports, Trade Publications, Clinical Trials Publications, Research Publications, Company Press Release, and some paid data sources.
  • In-house Data Analysis – After extensive data mining, we perform in-house market analysis by using various data tools, statistical methods, and data analysis tools to arrive on a conclusion and reduce the margin of error. We provide our overviews and market forecast for the target market after thoroughly understanding and analyzing of collected data, historic market trends, and research outputs.
  • Report Delivery – Prophecy Market Insights provide report in required electronic format (preferably in PDF format), as PDF format is easy to read and present.
How May I Help You ?

Facing difficulties to find research data that meet your requirement? We are here to assist you. Get in connect with our representative for your specific requirement.

Knowledge Center